Breast care considerations for transgender and gender-diverse patients (Q27660): Difference between revisions

From lgbtDB
Jump to navigation Jump to search
(‎Created a new Item)
 
(‎Added [en] label: Breast care considerations for transgender and gender-diverse patients)
 
label / enlabel / en
 
Breast care considerations for transgender and gender-diverse patients

Latest revision as of 00:47, 28 October 2024

No description defined
  • Breast care considerations for transgender and gender-diverse patients.
Language Label Description Also known as
English
Breast care considerations for transgender and gender-diverse patients
No description defined
  • Breast care considerations for transgender and gender-diverse patients.

Statements

Breast care considerations for transgender and gender-diverse patients. (English)
1 reference
Transgender and gender-diverse (TGD) persons represent a small but growing population in the United States. (English)
1 reference
Accessing inclusive, equitable, and evidence-based healthcare remains a challenge for this patient population. (English)
1 reference
Many TGD persons seek gender-affirming care, including gender-affirming hormonal therapy (GAHT) and gender-affirming surgery (GAS), to help ameliorate the physical and mental aspects of their gender incongruence. (English)
1 reference
Both GAHT and GAS induce clinically important histopathologic and anatomic changes in breast tissue. (English)
1 reference
Consequently, breast care in TGD persons has become an increasingly recognized topic of importance in gender-affirming care. (English)
1 reference
However, there remains a scarce but growing base of literature specifically addressing the unique healthcare needs of breast care in TGD patients. (English)
1 reference
This article will review how to establish trusting patient-provider relationships for TGD patients, gender inclusivity in breast clinics and imaging centers, the influence of GAHT and GAS on breast tissue, breast cancer screening recommendations and barriers, and breast cancer risk and treatment considerations in TGD persons. (English)
1 reference
2024
1 reference
2024
1 reference
20
1 reference
17455057241289706
1 reference
17455057241289706
1 reference
unknown value
1 reference
17455057241289706
1 reference
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (English)
1 reference